CSF excitatory amino acids and severity of illness in Alzheimer's disease

Neurology

Volumn 46, Issue 6, 1996, Pages 1715-1720

  Csernansky, J G ^a   Bardgett, M E ^a   Sheline, Y I ^a   Morris, J C ^a   Olney, J W ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; EXCITATORY AMINO ACID; GLUTAMIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID ANALYSIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; HUMAN; PRIORITY JOURNAL;

EID: 0029885421     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1715     Document Type: Article

References (35)

1. Graves AB, Kukull WA. The epidemiology of dementia. In: Morris JC, ed. The handbook of dementing illnesses. New York: Marcell Dekker, 1994.
2. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological findings in the neocortex in Alzheimer's disease. Proc Natl Acad Sci 1985;82:4531-4534.
3. Greenamyre JT, Maragos WF, Albin RL, Penney JB, Young AB. Glutamate transmission and toxicity in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1988;12: 421-430.
4. Olney JW. Excitotoxicity and neuropsychiatrie disorders. In: Ascher P, Choi DW, Christen Y, eds. Glutamate, cell death and memory. Berlin, Heidelberg: Springer Verlag: 1991.
5. McGale EHF, Pye IF, Stonier C, Hutchinson EC, Aber GM. Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977;29:291-297.
6. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
7. Berg L. Clinical dementia rating. Psychopharmacol Bull 1988; 24:637-639.
8. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
9. Berg L, Miller JP, et al. Mild senile dementia of the Alzheimer type. 2. Longitudinal assessment. Ann Neurol 1988;23:477-484.
10. Berg L, Miller JP, Baty J, Rubin EH, Morris JC, Figiel G. Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention. Ann Neurol 1992;31:242-249.
11. Burke WJ, Miller JP, et al. Reliability of the Washington University Clinical Dementia Rating (CDR). Arch Neurol 1988;45:31-32.
12. Berg L, Hughes CP, Coben LA, Danziger WL, Martin RL, Knesevich J. Mild senile dementia of the Alzheimer's type (SDAT): research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry 1982;45:962-968.
13. Morris JC, McKeel DW Jr, Fulling K, Torack RM, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 1988;24:17-22.
14. Berg L, Morris JC. Diagnosis. In: Alzheimer disease. Terry RD, Katzman R, Bick KL, eds. New York: Raven Press, 1994.
15. Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol 1989;46:379-382.
16. Morris JC, McKeel DW, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41:469-478.
17. Storandt M, Botwinick J, Danziger WL, Berg L, Hughes CP. Psychometric differentiation of mild senile dementia of the Alzheimer type. Arch Neurol 1984;41:497-499.
18. Storandt M, Hill RD. Very mild dementia of the Alzheimer type. II. Psychometric test performance. Arch Neurol 1989;46: 383-386.
19. Wechsler D, Stone CP. Manual: Wechsler Memory Scale. New York: Psychological Corporation, 1973.
20. Duchek JM, Cheney M, Ferraro R, Storandt M. Paired associate learning in senile dementia of the Alzheimer type. Arch Neurol 1991;48:1038-1040.
21. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test scoring booklet. Philadelphia: Lea and Febiger, 1983.
22. Armitage SG. An analysis of certain psychological tests used in the evaluation of brain injury. Psychological Monographs 1946;60:1-48.
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edition, revised. Washington, D.C.: American Psychiatric Association, 1987.
24. Gattaz WF, Gattaz D, Beckmann H. Glutamate in schizophrenics and healthy controls. Arch Psychiatry Neurol Sci 1982;231:221-225.
25. Ferrarese C, Pecora NB, Frigo M, Appollonio I, Frattola L. Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 1993;33:316-319.
26. Donzanti BA, Yamamoto BK. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 1988;43:913-922.
27. van Gool WA, Bolhuis PA. Cerebrospinal fluid markers of Alzheimer's disease. J Am Geriatr Soc 1991;39:1025-1039.
28. Smith CCT, Bowen DM, Francis PT, Snowden JS, Neary D. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 1985;48:469-471.
29. Degrell I, Hellsing K, Nagy E, Niklasson F. Amino acid concentrations in cerebrospinal fluid of presenile and senile dementia of the Alzheimer type and multi-infarct dementia. Arch Gerontol Geriatr 1989;9:123-135.
30. Proctor AW, Palmer AM, et al. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem 1988;50:790-802.
31. Martinez M, Frank A, Diez-Tejedor E, Hernanz A. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. J Neural Transm Park Dis Dement Sect 1993;6:1-9.
32. Pomara N, Singh R, Deptula D, Chou JC-Y, Schwartz MB, LeWitt PA. Glutamate and other CSF amino acids in Alzheimer's disease. Am J Psychiatry 1992;149:251-254.
33. Toghi H, Abe T, Takahashi S, Kimura M. A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with Alzheimer type dementia compared with vascular dementia of the Binswanger type. Neurosci Lett 1992;141:5-8.
34. Procter AW, Palmer AM, Francis PT, et al. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem 1988;50:790-802.
35. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13:71-82.